Variman Global Enterprises Ltd has officially withdrawn its proposal to acquire a 99.99% stake in Scotland-based Ecogenics Technologies and Systems Limited. The board cited the non-receipt of mandatory PAN details from the target's shareholders as the reason for calling off the deal. Consequently, the company has also rescinded its plan to increase its authorized share capital, which was previously slated to rise from Rs 50 crore to Rs 67 crore. This development halts the intended share swap deal involving 41.07 crore equity shares.
Variman Global Scraps Acquisition Plan Following Compliance Hurdles
- Acquisition of 99.99% stake in Ecogenics Technologies and Systems Limited stands withdrawn.
- Proposed authorized share capital increase from Rs 50 crore to Rs 67 crore rescinded.
Reader Takeaway: The deal was cancelled due to documentation failure, removing imminent share dilution pressure on existing shareholders.
What just happened
Variman Global Enterprises Ltd has officially cancelled its proposal to acquire a 99.99% stake in the Scottish entity, Ecogenics Technologies and Systems Limited. The board reached this decision through a circular resolution passed on September 7, 2026. The acquisition was originally announced on August 29, 2026, and was intended to be executed via a share swap.
Why this matters
The deal required the issuance of over 41 crore equity shares at Rs 4.65 per share. Because the selling shareholders failed to provide mandatory PAN details, Variman Global could not proceed with the necessary in-principle application to the BSE. Without these regulatory filings, the board determined it was impossible to move forward with the acquisition or present the required resolutions to shareholders.
What changes now
With the acquisition off the table, the company has automatically abandoned its plan to expand its authorized share capital. The proposed increase to Rs 67 crore, intended to accommodate the new share issuance, will no longer occur. The authorized capital remains at Rs 50 crore. This development effectively stops the planned share dilution that would have resulted from the acquisition.
What to track next
Investors should monitor official disclosures for any future inorganic growth plans or attempts to revisit this acquisition if the documentation hurdles are cleared, though none have been indicated at this stage.
